Subscribe To
Viking therapeutics: a promising nash diversification play
Following positive data for its obesity drug (VK2735), Viking Therapeutics shares rallied aggressively. In Q2, Viking is poised to release its ...
April 4, 2023, 7:56 am
Algernon pharmaceuticals announces successful dosing of second cohort in phase 1 dmt clinical study
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its subsidiary Algernon NeuroScience (AGN Neuro) has completed dosing of the second cohort ...
April 4, 2023, 7:46 am
Baker (bkr) secures contract for port arthur phase i project
Baker Hughes (BKR) to supply essential LNG liquefaction equipment for the Port Arthur LNG phase I Proje...
April 3, 2023, 9:07 am
Gossamer bio: merck's stellar data impressive, but game not over for seralutinib
Merck's Sotatercept showed significant improvements in PAH patients in phase 3 STELLAR trial with a pri...
April 2, 2023, 4:12 am
Gm plans to phase out apple carplay in evs, with google's help
General Motors plans to phase out widely used Apple CarPlay and Android Auto technologies that allow dr...
April 1, 2023, 11:05 am
Could this drug news lift abbvie's stock?
Rinvoq recently moved into phase 3 clinical trials for what could be its seventh indication. If approve...
April 1, 2023, 9:15 am
Medpace holdings: priced with high expectations
Cincinnati-based Medpace provides the biotechnology world with phase 1-IV clinical development services...
April 1, 2023, 8:44 am
Travere therapeutics announces interim analysis from the phase 3 protect study of filspari™ (sparsentan) in iga nephropathy published in the lancet and presented at world congress of nephrology 2023
FILSPARI demonstrated a statistically significant, rapid, and sustained decline of proteinuria compared to the active control SAN DIEGO, April 01, 202...
April 1, 2023, 8:30 am
Xle or xop? the energy sector is powering up
The energy sector's been in a high level consolidation for almost a year and has, so far, avoided the bear market. However, this consolidation ...
April 1, 2023, 12:54 am
Belite bio reports full-year 2022 operational highlights and financial results
12-month interim data from the ongoing 2-year, phase 2 Stargardt disease (STGD1) study continues to sho...
March 31, 2023, 11:03 pm
Are big tech stocks the next safe haven investment?
While 2023 has featured the return of the flight to safety trade, where Treasuries have been able to counteract some of the risks of equities, the mar...
March 31, 2023, 3:54 pm
Teck says first copper concentrate produced at qb2 project in chile
(Kitco News) - Teck Resources (TSX: TECK.A and TECK.B) (NYSE: TECK) today announced its Quebrada Blanca phase ...
March 31, 2023, 2:33 pm
Avidity (rna) down on update from neuromuscular disease study
Avidity Biosciences (RNA) provides an update on its phase I/II study of its lead product candidate AOC ...
March 31, 2023, 1:04 pm
First quantum, rio tinto form partnership to progress the la granja copper project in peru
(Kitco News) - Major copper producer First Quantum Minerals (TSX: FM) announced yesterday that it has entered into an agreement with Rio Tinto to prog...
March 31, 2023, 12:18 pm
Cytokinetics announces courage-als met criteria for futility at second interim analysis
Company Plans to Discontinue the phase 3 Clinical Trial of Reldesemtiv After Data Monitoring Committee ...
March 31, 2023, 11:30 am
Disc medicine reports full year 2022 financial results and provides business update
Completed reverse merger with Gemini Therapeutics, debuting on Nasdaq as “IRON” and ending 2022 with approximately $194.6 million in cash and cash...
March 31, 2023, 11:00 am
Gm plans to phase out apple carplay in evs, with google's help
General Motors plans to phase out widely-used Apple CarPlay and Android Auto technologies that allow dr...
March 31, 2023, 10:03 am
Eledon reports data from ongoing phase 1b trial evaluating tegoprubart in patients undergoing kidney transplantation at world congress of nephrology
Results from three participants demonstrated no incidence of acute rejection at durations of 56, 154, and 232 days Strong graft function observed in a...
March 31, 2023, 10:00 am
This blockbuster drug's latest news could be another home run for abbvie
Skyrizi's recently announced phase 3 clinical trial results to treat ulcerative colitis demonstrate tha...
March 31, 2023, 8:50 am
Emis slides after cma refers takeover by unitedhealth to in-depth probe
EMIS Group plc (AIM:EMIS) shares dived 22.3% to 1408p after the connected healthcare software and services company's proposed £1.2bn takeover by Unit...
March 31, 2023, 5:07 am